Moreover, electronic tools like m-health applications assist patients in remaining on track regarding the use of medications and adopting new habits
Originally developed for the management of type 2 diabetes, semaglutide has also shown promise in the field of weight management
The development of novel dual- or triple-receptor agonists that bind to the receptors not only for GLP-1 but also to the receptors for glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon is intended to address different metabolic pathways for carbohydrate, lipid, and protein metabolism simultaneously
Overall, these collective effects reduce food intake, increase satiety, and improve glucose metabolism, which can lead to robust weight loss, Rhodes says
GLP-1 medications may help reduce food noise by supporting your bodys natural hunger and fullness signaling